Off-label prescription: experience is a gloomy lantern that does not even illuminate its bearer. Author response

Aviv Ladanie; John P A Ioannidis; Randall S. Stafford; Hannah Ewald; Heiner C. Bucher; Lars G. Hemkens; Lars G. Hemkens

doi:10.1016/j.jclinepi.2018.05.012

Related publications

Article1980

A fluorescent analogue of propranolol does not label beta adrenoceptor sites

Peter J Barnes, H. Koppel, Paul Lewis, Christine Hutson, Ian A. Blair, C. T. Dollery

Letter2023

Although serotonin is not a major player in depression, its precursor is

Abbas F. Almulla, Michael Maes

Article2009

Author's Response: Heterogeneity metrics: not perfect, but would not abandon

Nikolaos A. Patsopoulos, John P A Ioannidis

Article2024

Psychiatric Comorbidity Does Not Enhance Prescription Opioid Use in Inflammatory Bowel Disease as It Does in the General Population

Çharles N. Bernstein, John D. Fisk, Randy Walld, Jitender Sareen, Scott Burton Patten, Alexander Singer, Lisa M. Lix, Carol Hitchon, Renée El‐Gabalawy, Alan Katz, Lesley A. Graff, Jitender Sareen, Scott Burton Patten, Alexander Singer, Lisa M. Lix, Carol Hitchon, Renée El‐Gabalawy, John D. Fisk, Lesley A. Graff, Lindsay Berrigan, Ryan Zarychanski, Christine Peschken,

Article2012

Primary PCI during off-hours is not related to increased mortality

Sanneke PM de Boer, Rohit M. Oemrawsingh, Mattie Lenzen, Nicolas M. Van Mieghem, Carl Schultz, K. Martijn Akkerhuis, Maarten AH van Leeuwen, Felix Zijlstra, Ron T. van Domburg, Patrick W. Serruys, Eric Boersma

European Heart Journal Acute Cardiovascular Care